FNY Partners Fund’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

FNY Partners Fund’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$5K	Buy	+8	New	+$6K	﹤0.01%	294

Other funds holding HTGM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWP

Private Wealth Partners Mill Valley, California $1.4B AUM 36.82% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $34.8M AUM 275.91% 1-Year Est. Return

FNY Partners Fund's HTGM Position: Q1 2018 in Review

FNY Partners Fund opened a new position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q1 2018: 8 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #294 among its holdings.

41 funds tracked by Wall St. Rank hold HTGM as of Q1 2018.

FNY Partners Fund held 8 shares of HTG Molecular Diagnostics, Inc. Common Stock worth $5K as of Q1 2018.
HTG Molecular Diagnostics, Inc. Common Stock was a new FNY Partners Fund position in Q1 2018.
HTG Molecular Diagnostics, Inc. Common Stock made up ﹤0.01% of FNY Partners Fund's portfolio in Q1 2018, its #294 holding.
41 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.